实验性关节炎中浆细胞样树突状细胞的治疗性调控
本研究利用K/BxN血清诱导关节炎、胶原诱导关节炎及人TNF转基因插入小鼠模型,探讨浆细胞样树突状细胞(PDC)和I型干扰素在类风湿关节炎中的作用。PDC缺陷小鼠在关节源性血清转移后炎症和关节炎症状加重,而局部应用TLR-7激动剂咪喹莫特增强PDC募集和活化可显著改善多种模型关节炎。咪喹莫特诱导干扰素特征并减少炎症细胞浸润,其疗效依赖PDC的TLR-7感知和I型干扰素信号。
要点
- PDC缺陷小鼠在关节源性血清转移后炎症和关节炎症状加重。
- 局部应用TLR-7激动剂咪喹莫特可显著改善多种小鼠模型关节炎。
- 咪喹莫特疗效依赖PDC的TLR-7感知和I型干扰素信号。
核心结论
- 局部募集和活化PDC是类风湿关节炎有吸引力的治疗机会。
研究设计与样本
- 研究纳入K/BxN血清诱导关节炎、胶原诱导关节炎和人TNF转基因插入小鼠模型。
- 通过视觉评分、爪肿胀定量、酶联免疫吸附试验测细胞因子及组织学分析评估症状。
- 通过转录组分析(定量逆转录聚合酶链反应)和关节周围组织流式细胞术监测咪喹莫特疗效。
主要发现
- PDC缺陷小鼠在关节源性血清转移后炎症和关节炎症状加重。
- 局部应用TLR-7激动剂咪喹莫特增强PDC向关节炎关节募集和活化,显著改善多种小鼠模型关节炎。
- 咪喹莫特诱导干扰素特征并减少炎症细胞浸润。
临床怎么用
- 局部募集和活化PDC可能成为类风湿关节炎的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The role of plasmacytoid dendritic cells (PDCs) and type I interferons (IFNs) in rheumatoid arthritis (RA) remains a subject of controversy. This study was undertaken to explore the contribution of PDCs and type I IFNs to RA pathogenesis using various animal models of PDC depletion and to monitor the effect of localized PDC recruitment and activation on joint inflammation and bone damage. METHODS: Mice with K/BxN serum-induced arthritis, collagen-induced arthritis, and human tumor necrosis factor transgene insertion were studied. Symptoms were evaluated by visual scoring, quantification of paw swelling, determination of cytokine levels by enzyme-linked immunosorbent assay, and histologic analysis. Imiquimod-dependent therapeutic effects were monitored by transcriptome analysis (using quantitative reverse transcriptase-polymerase chain reaction) and flow cytometric analysis of the periarticular tissue. RESULTS: PDC-deficient mice showed exacerbation of inflammatory and arthritis symptoms after arthritogenic serum transfer. In contrast, enhancing PDC recruitment and activation to arthritic joints by topical application of the Toll-like receptor 7 (TLR-7) agonist imiquimod significantly ameliorated arthritis in various mouse models. Imiquimod induced an IFN signature and led to reduced infiltration of inflammatory cells. CONCLUSION: The therapeutic effects of imiquimod on joint inflammation and bone destruction are dependent on TLR-7 sensing by PDCs and type I IFN signaling. Our findings indicate that local recruitment and activation of PDCs represents an attractive therapeutic opportunity for RA patients.
引用
- Nehmar R, Alsaleh G, Voisin B, et al. Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental Arthritis. Arthritis Rheumatol. 2017. PMID: 28777892. doi:10.1002/art.40225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。